INS and metabolic dysfunction-associated steatotic liver disease: When plasma glucose levels are high, insulin, a hormone produced by pancreatic beta cells, inhibits gluconeogenesis under physiological conditions, but when peripheral tissues are resistant to insulin, gluconeogenesis in the liver increases, which leads to nonalcoholic fatty liver disease (NAFLD) [1].